Clinical Trial Update: Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of ATX-101 (deoxycholic acid) injections to reduce submental fat; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fullness

Drugs mentioned

• ATX-101 (deoxycholic acid injection) (deoxycholic acid)

Snippet

Sponsor: Kythera Biopharmaceuticals | Conditions: Moderate or Severe Submental Fullness | Phase 3 | Status: COMPLETED | Results posted: 2015-06-12